MECOM and chronic myelogenous leukemia, BCR-ABL1 positive: These results are consistent with our expression profiling of human CML samples showing an inverse correlation between Evi1 and PTEN levels and a tendency of Evi1 to be activated as the disease progresses from the chronic phase to blastic crisis [33].